Abiopharma

🔍 Eagle Point Credit Management LLC (Executive)

Company: ACRES Commercial Realty Corp. (ACR)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 908 shares of 7.875% Series D Preferred Stock at $21.8 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 715,771.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 84 shares of 7.875% Series D Preferred Stock at $21.8 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 715,687.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock, $0.001 par value (Direct)
  Date: 2026-07-30 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 1,177,060.00 | Footnotes: F1
• Holds 0 shares of 8.625% Series C Preferred Stock (Direct)
  Date: 2026-07-30 | Code: H | nature_of_ownership: See footnotes | shares_owned_after: 339,325.00 | Footnotes: F1

Footnotes:

• F1: The securities are directly held by certain private investment funds and/or certain accounts (the "Applicable Accounts") managed by Eagle Point Credit Management LLC ("EPCM"). Eagle Point DIF GP I LLC ("DIF GP") serves as general partner to certain Applicable Accounts.
• F2: EPCM and DIF GP could be deemed to have an "indirect pecuniary interest" (within the meaning of Rule 16a-1(a)(2)(ii) under the Securities Exchange Act of 1934) in securities reported herein.
• F3: Each of the Reporting Persons hereby disclaims beneficial ownership of the securities described in this report pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934 and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of any of the reported securities for purposes of Section 16 or for any other purpose.